Disclosure Of Fair Value Measurement [Text Block]

Sopharma AD - Filing #6022427

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
1,204,978,000 BGN
1,242,112,000 BGN
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
546,110,000 BGN
675,517,000 BGN
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
50,284,000 BGN
444,634,000 BGN
66,201,000 BGN
36,788,000 BGN
12,512,000 BGN
658,868,000 BGN
1,644,000 BGN
646,975,000 BGN
11,893,000 BGN
682,000 BGN
134,798,000 BGN
2,685,000 BGN
134,798,000 BGN
566,595,000 BGN
360,770,000 BGN
2,282,000 BGN
- BGN
63,335,000 BGN
28,425,000 BGN
553,269,000 BGN
33,656,000 BGN
13,326,000 BGN
360,770,000 BGN
63,335,000 BGN
13,326,000 BGN
28,425,000 BGN
553,269,000 BGN
134,798,000 BGN
- BGN
33,656,000 BGN
2,685,000 BGN
566,595,000 BGN
2,282,000 BGN
34,142,000 BGN
2,873,000 BGN
134,798,000 BGN
360,656,000 BGN
575,772,000 BGN
59,297,000 BGN
28,871,000 BGN
- BGN
19,341,000 BGN
4,078,000 BGN
556,431,000 BGN
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.